PT933995E - Metodo para tratamento de lesao endotelial - Google Patents
Metodo para tratamento de lesao endotelialInfo
- Publication number
- PT933995E PT933995E PT97940974T PT97940974T PT933995E PT 933995 E PT933995 E PT 933995E PT 97940974 T PT97940974 T PT 97940974T PT 97940974 T PT97940974 T PT 97940974T PT 933995 E PT933995 E PT 933995E
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- epo
- endothelial lesion
- lesion
- endothelial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/712,358 US20020052309A1 (en) | 1996-09-11 | 1996-09-11 | Method of treating endothelial injury |
Publications (1)
Publication Number | Publication Date |
---|---|
PT933995E true PT933995E (pt) | 2005-02-28 |
Family
ID=24861777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97940974T PT933995E (pt) | 1996-09-11 | 1997-09-10 | Metodo para tratamento de lesao endotelial |
Country Status (12)
Country | Link |
---|---|
US (5) | US20020052309A1 (pt) |
EP (1) | EP0933995B8 (pt) |
JP (3) | JP2001503028A (pt) |
CN (2) | CN1113669C (pt) |
AT (1) | ATE282425T1 (pt) |
CA (1) | CA2265547C (pt) |
DE (1) | DE69731652T2 (pt) |
DK (1) | DK0933995T3 (pt) |
ES (1) | ES2231889T3 (pt) |
HK (1) | HK1022810A1 (pt) |
PT (1) | PT933995E (pt) |
WO (1) | WO1998010650A1 (pt) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2686899B1 (fr) * | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
IL124015A0 (en) * | 1998-04-08 | 1999-01-26 | Yeda Res & Dev | Pharmaceutical compositions comprising a protein |
FR2786104B1 (fr) * | 1998-11-25 | 2002-12-27 | Centre Nat Rech Scient | Inhibiteurs de l'activation de nf-kb, et leurs utilisations pharmaceutiques |
US7410941B1 (en) | 1999-04-13 | 2008-08-12 | The Kenneth S. Warren Institute, Inc. | Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin |
EA004766B1 (ru) * | 1999-04-13 | 2004-08-26 | Дзе Кеннет С. Уоррен Инститьют, Инк. | Модуляция функции возбуждаемых тканей за счет периферического введения эритропоэтина |
US7345019B1 (en) * | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
US6171620B1 (en) | 1999-04-27 | 2001-01-09 | Health Research, Inc. | Method of enhancing the efficacy of anti-tumor agents |
PL360581A1 (en) * | 1999-05-11 | 2004-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
US20030152562A1 (en) * | 2001-10-23 | 2003-08-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Vitro micro-organs, and uses related thereto |
EP2266607A3 (en) | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
US20020061849A1 (en) * | 2000-05-02 | 2002-05-23 | Soren Nielsen | Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
DE60131393D1 (de) * | 2000-05-02 | 2007-12-27 | Action Pharma As | Verfahren zur behandlung von erkrankungen assoziiert mit akuten entzündung unter nichtischämischen zustände |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
US7767643B2 (en) | 2000-12-29 | 2010-08-03 | The Kenneth S. Warren Institute, Inc. | Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
US20020169128A1 (en) * | 2001-04-09 | 2002-11-14 | Geroge Sigounas | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
EP1930023A3 (en) * | 2001-04-09 | 2008-08-06 | East Carolina University | Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
AU2002310122A1 (en) * | 2001-05-25 | 2002-12-09 | Human Genome Sciences, Inc. | Chemokine beta-1 fusion proteins |
ATE399561T1 (de) * | 2001-11-02 | 2008-07-15 | Yoshiko Yasuda | Verwendung von emp9 zur prävention von proliferativen organerkrankungen |
EP1997829A1 (en) * | 2001-12-21 | 2008-12-03 | Human Genome Sciences, Inc. | Albumin fusion proteins |
GB0211578D0 (en) * | 2002-05-21 | 2002-06-26 | Univ Belfast | Medicaments |
DE10234192B4 (de) * | 2002-07-26 | 2009-11-26 | Epoplus Gmbh Co.Kg | Verwendung von Erythropoetin |
MXPA06003234A (es) * | 2003-09-29 | 2006-06-08 | Warren Pharmaceuticals Inc | Citosinas protectoras de los tejidos para el tratamiento y prevencion de la sepsis y la formacion de adhesiones. |
WO2005094236A2 (en) * | 2003-11-07 | 2005-10-13 | Henry M. Jackson Foundation | Activation of hypoxia-inducible gene expression |
DE102004063927A1 (de) * | 2004-01-23 | 2005-12-15 | Epoplus Gmbh Co.Kg | Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden |
WO2005099773A1 (en) * | 2004-04-05 | 2005-10-27 | University Of Vermont And State Agricultural College | Use of erythropoietin for treatment of cancer |
US20110076255A1 (en) * | 2005-11-07 | 2011-03-31 | Pecora Andrew L | Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency |
US20080249001A1 (en) * | 2006-10-25 | 2008-10-09 | Ajinomoto Co. Inc. | Agents that alleviate side-effects caused by chemotherapy agents |
US9533010B2 (en) * | 2011-10-31 | 2017-01-03 | Amorcyte, Llc | Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency |
JP6426693B2 (ja) * | 2013-03-15 | 2018-11-21 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 抗cd47薬の処理上有効量を達成するための方法 |
EP4340865A1 (en) * | 2021-05-18 | 2024-03-27 | Attias, Eyal | Use of erythropoietin (epo) or erythropoiesis-stimulating agent (esa) to treat osteomyelitis, bone infection, and bone inflammation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
US4745099A (en) * | 1985-02-06 | 1988-05-17 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition for the treatment of the anemia of malignant tumors |
US5002755A (en) * | 1988-02-18 | 1991-03-26 | Vanderbilt University | Method of controlling nephrotoxicity of anti-tumor plaintum compounds |
JP2632014B2 (ja) * | 1988-03-03 | 1997-07-16 | 中外製薬株式会社 | 骨髄機能障害性貧血治療剤 |
US5716644A (en) * | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
JPH0782174A (ja) * | 1993-09-17 | 1995-03-28 | Takeda Chem Ind Ltd | 抗腫瘍剤 |
US5626862A (en) * | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
JP2001520503A (ja) * | 1994-12-30 | 2001-10-30 | カイロン コーポレイション | インビボにおける固形腫瘍の処置のための方法および組成物 |
US5635160A (en) * | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
-
1996
- 1996-09-11 US US08/712,358 patent/US20020052309A1/en not_active Abandoned
-
1997
- 1997-04-15 US US08/842,700 patent/US5922674A/en not_active Expired - Lifetime
- 1997-09-10 ES ES97940974T patent/ES2231889T3/es not_active Expired - Lifetime
- 1997-09-10 AT AT97940974T patent/ATE282425T1/de active
- 1997-09-10 DE DE69731652T patent/DE69731652T2/de not_active Expired - Lifetime
- 1997-09-10 DK DK97940974T patent/DK0933995T3/da active
- 1997-09-10 JP JP10513794A patent/JP2001503028A/ja not_active Withdrawn
- 1997-09-10 WO PCT/US1997/015966 patent/WO1998010650A1/en active IP Right Grant
- 1997-09-10 EP EP97940974A patent/EP0933995B8/en not_active Revoked
- 1997-09-10 CN CN97199338A patent/CN1113669C/zh not_active Expired - Fee Related
- 1997-09-10 CA CA002265547A patent/CA2265547C/en not_active Expired - Fee Related
- 1997-09-10 PT PT97940974T patent/PT933995E/pt unknown
-
2000
- 2000-03-15 US US09/525,797 patent/US7531501B1/en not_active Expired - Fee Related
- 2000-03-23 HK HK00101826A patent/HK1022810A1/xx not_active IP Right Cessation
-
2002
- 2002-11-12 CN CNB021506884A patent/CN1250281C/zh not_active Expired - Fee Related
-
2007
- 2007-06-29 US US11/771,470 patent/US7803408B2/en not_active Expired - Fee Related
-
2008
- 2008-02-28 JP JP2008048009A patent/JP2008133305A/ja active Pending
-
2009
- 2009-03-31 JP JP2009086240A patent/JP2009196999A/ja active Pending
- 2009-07-27 US US12/509,841 patent/US20090285908A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090285908A1 (en) | 2009-11-19 |
EP0933995B1 (en) | 2004-11-17 |
ATE282425T1 (de) | 2004-12-15 |
US7803408B2 (en) | 2010-09-28 |
DE69731652T2 (de) | 2005-12-15 |
EP0933995B8 (en) | 2005-01-19 |
CN1250281C (zh) | 2006-04-12 |
DK0933995T3 (da) | 2005-02-14 |
ES2231889T3 (es) | 2005-05-16 |
EP0933995A1 (en) | 1999-08-11 |
CN1429623A (zh) | 2003-07-16 |
JP2008133305A (ja) | 2008-06-12 |
DE69731652D1 (de) | 2004-12-23 |
CN1235512A (zh) | 1999-11-17 |
US20020052309A1 (en) | 2002-05-02 |
CA2265547C (en) | 2009-12-01 |
JP2001503028A (ja) | 2001-03-06 |
EP0933995A4 (en) | 2002-08-28 |
HK1022810A1 (en) | 2000-08-25 |
US5922674A (en) | 1999-07-13 |
JP2009196999A (ja) | 2009-09-03 |
CN1113669C (zh) | 2003-07-09 |
US20080124401A1 (en) | 2008-05-29 |
US7531501B1 (en) | 2009-05-12 |
WO1998010650A1 (en) | 1998-03-19 |
CA2265547A1 (en) | 1998-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT933995E (pt) | Metodo para tratamento de lesao endotelial | |
DE60026538D1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
CY1105818T1 (el) | Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου | |
PT927150E (pt) | Compostos de lipoxina e sua utilizacao no tratamento de doencas proliferativas celulares | |
MX9302038A (es) | Metodo para el tratamiento del cancer por una terapia conjunta con derivados de 2-halometilideno y un agente antineoplasico especifico de fase m o fase s. | |
BR0107705A (pt) | Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva | |
AR023400A1 (es) | Metodos para inducir la muerte de celulas cancerosas y la regresion de tumores | |
ES2137554T3 (es) | 2-(2-amino-3-metoxifenil)-4-oxo-4h-(1)benzopirano para el tratamiento de desordenes proliferantes. | |
CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
ES2153862T3 (es) | Bisulfan de administracion parenteral para el tratamiento de enfermedades malignas. | |
AU6256996A (en) | Use of vitamin D4 derivatives for treating skin disorders | |
IL97192A0 (en) | Apparatus for surgical hyperthermia treatment of tissue,preferably the prostate,the apparatus including dilation means | |
WO2000061141A3 (en) | Methods and compositions for enhancing delivery of therapeutic agents to tissues | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
WO2023164455A3 (en) | Compositions and methods to modulate the immune system | |
EP0950416A4 (en) | Preventive and / or therapeutic agent against cachexia | |
GB9004348D0 (en) | New use of catechol derivatives and their physiologically acceptable salts and esters | |
ES2058161T3 (es) | Producto activo para la lucha contra tumores. | |
DE69517302D1 (de) | Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen | |
DK0455769T3 (da) | Anvendelse af 7-OH-1,2-benzopyron til fremstilling af et lægemiddel til behandling af magline tumore r hos mennesker | |
Evtushenko et al. | Laser therapy in children's oncology | |
MX9203715A (es) | Preparciones para el tratamiento del tejido aloinjertado. | |
UA31283A (uk) | Спосіб вилучення пухлини зорового нерву орбітальної локалізації | |
IT1264428B1 (it) | Composizioni farmaceutiche per il trattamento della psoriasi |